Formulated in ISO Class 8 (100,000 Level) Cleanrooms using 100% Ultra-Pure Medical-Grade Polydimethylsiloxanes and Bio-Compatible Elastomer Matrices.
In modern dermatological surgery, plastic reconstruction, and trauma care, topically applied silicone gel represents the gold standard for non-invasive scar management. Supported by over three decades of clinical consensus published in international cosmetic and reconstructive surgery journals, high-molecular-weight silicone polymers effectively manage hypertrophic scars, keloids, post-caesarean marks, cosmetic incisions, and burn contractures. As a premier CE certified OEM silicone scar gel manufacturer and exporter, our R&D division engineers medical-grade formulations based on exact biophysical interaction models with the human stratum corneum.
When human dermal tissue suffers full-thickness or partial-thickness trauma (whether via surgical incision, thermal burn, or mechanical laceration), the newly regenerated epidermis lacks mature stratum corneum structures. Consequently, TEWL increases dramatically—often up to 4 to 5 times above normal physiological levels. This elevated water evaporation induces localized cellular dehydration within keratinocytes.
Dehydrated keratinocytes synthesize osmotic stress signals, releasing pro-inflammatory cytokines such as Interleukin-1 alpha (IL-1α) and Transforming Growth Factor-Beta 1 (TGF-β1). These cytokines penetrate into the deep dermal layer, triggering continuous activation of dermal fibroblasts. Overactive fibroblasts continuously deposit disorganized Type I and Type III collagen fibers, leading directly to raised, rigid, erythematous hypertrophic scars or aggressive keloid tissue.
Our custom-manufactured silicone scar gels apply a cross-linked matrix of Polydimethylsiloxane (PDMS) and Cyclopentasiloxane (D5). Upon topical application, the volatile siloxane vehicle evaporates seamlessly, leaving behind an invisible, continuous, bio-compatible silicone film measuring between 4 to 5 micrometers in thickness. This micro-layer restores TEWL to normal physiological rates (~10-12 g/m²/hr) without occluding oxygen exchange, signaling keratinocytes to cease pro-fibrotic cytokine production and stabilizing collagen homeostasis.
The primary molecular driver of pathologic scarring is the hyperactivation of the TGF-β signaling cascade. Specifically, elevated ratios of TGF-β1 relative to TGF-β3 cause abnormal accumulation of extracellular matrix (ECM) proteins. Medical silicone gel application alters the localized micro-environmental tension and bio-electrical properties of the scar matrix:
Restores parallel micro-alignment of newly synthesized collagen fibers along tissue strain lines rather than chaotic whorl patterns.
Stimulates collagenase (MMP-1) production, facilitating the enzymatic degradation of excess collagen bundles in mature scars.
Reduces localized capillary hyper-perfusion, significantly diminishing scar redness, itching, and tension pain within 2 to 4 weeks.
As an advanced OEM contract manufacturer, our engineering capabilities extend beyond basic siloxane mixtures. We formulate specialized hybrid silicone matrices capable of stably carrying oil-soluble and water-dispersible active pharmaceutical and cosmetic ingredients without disrupting the hydrophobic film integrity.
| Active Ingredient Compound | Biochemical Synergy | Target Clinical Indication | OEM Customization Options |
|---|---|---|---|
| Tetrahexyldecyl Ascorbate (V-C Ester) | Lipid-soluble Vitamin C derivative; inhibits melanogenesis and reduces post-inflammatory hyperpigmentation (PIH). | Darkened post-surgical scars & pigmented acne lesions. | 0.5% to 5.0% concentration infilling with stability testing. |
| Allium Cepa (Onion Extract) | Contains quercetin and kaempferol; acts as an anti-inflammatory and inhibits fibroblast proliferation. | Hypertrophic & burn scar contractures. | Odour-masked, purified botanical extract integration. |
| Micronized Zinc Oxide & Titanium Dioxide | Provides broad-spectrum non-chemical physical photoprotection (SPF 30 to SPF 50+). | Facial scars exposed to ambient sunlight. | Transparent non-nano dispersion, zero white cast finish. |
| Centella Asiatica (Asiaticoside / Madecassoside) | Accelerates epithelial micro-repair and enhances structural glycosaminoglycan synthesis. | Fresh post-procedure skin & laser resurfacing recovery. | Medical grade purity >98% standardized titration. |
The global scar treatment market is experiencing unprecedented demand, projected to exceed USD 35 Billion by 2032 with a CAGR of 9.8%. B2B buyers, pharmaceutical distributors, hospital supply chains, and direct-to-consumer medical aesthetics brands are reshaping their procurement strategies around several key market shifts:
While traditional silicone gel sheets remain popular for flat bodily areas, patient compliance drops significantly when treating facial scars, joint flexures, or sensitive post-cosmetic surgery zones (e.g., blepharoplasty, rhinoplasty, breast augmentation). Topical silicone gel provides a self-drying, flexible, friction-free alternative that can be worn under cosmetics and sunscreen, leading pharmaceutical brand owners to shift up to 70% of their private-label scar care budgets toward liquid silicone gel tubes and precision airless applicators.
The global regulatory landscape for medical devices has tightened drastically. The European Union’s transition from the Medical Device Directive (MDD) to the rigorous Medical Device Regulation (MDR 2017/745) requires detailed Technical Documentation, Clinical Evaluation Reports (CER), and rigorous continuous Post-Market Surveillance (PMS).
B2B buyers can no longer rely on uncertified cosmetic-grade manufacturers. Strategic brand owners are partnering exclusively with accredited contract manufacturers holding certified ISO 13485:2016 Medical Device Quality Management Systems and pre-validated CE Class I / IIa technical dossiers to ensure smooth market access across Europe, the Middle East, Southeast Asia, and the Americas.
With the rapid growth of healthcare markets across ASEAN (Malaysia, Indonesia, Thailand) and the GCC region (UAE, Saudi Arabia, Qatar), there is a massive surge in demand for JAKIM Halal-certified medical device manufacturing. Importers and hospital procurement networks require scar care formulations made without animal-derived lipids, alcohol, or haram ingredients, produced in certified cleanrooms that adhere to strict cross-contamination protocols.
Precision nozzle tubes, ceramic cooling tips, and dual-chamber airless pumps preventing compound oxidation.
Complete CTD / CSDT dossier preparation, COA, MSDS, Stability Reports, and FSC (Free Sale Certificates).
Support for both high-volume pharmaceutical rollouts and agile low-MOQ private label launches starting from 3,000 units.
As a forward-thinking OEM/ODM scar gel exporter, our dedicated analytical chemistry and polymer synthesis laboratories actively invest in next-generation material science. Our R&D pipeline integrates emerging biomedical technologies into topical scar management systems:
The future of scar remodeling lies in cell-signaling crosstalk. We are engineering hybrid cross-linked silicone gels capable of encapsulating plant-derived exosomes and biomimetic signal peptides (such as Copper Tripeptide-1 and Palmitoyl Pentapeptide-4). Encapsulated within protective lipid nanocarriers inside the silicone film, these bio-actives release gradually over 12 hours to accelerate extracellular matrix remodeling while suppressing abnormal fibrotic scarring.
In response to global sustainability directives, our silicone chemistry team is developing eco-conscious bio-silicones synthesized using renewable quartz silica and green carrier fluids. These bio-sourced polymers deliver identical gas-permeability, biocompatibility, and non-tacky tactile properties as traditional petroleum-derived siloxanes, empowering eco-driven brands to lead the sustainable medical device movement.
Next-generation silicone scar therapeutics incorporate smart dynamic viscoelasticity. Under mechanical shear stress (such as joint flexion, facial movement, or clothing friction), the polymer matrix temporarily thins to maintain skin comfort, immediately reforming its cohesive protective barrier once shear forces cease. This ensures uninterrupted 24-hour scar therapy even over high-mobility anatomical sites.
Backed by over 20 years of manufacturing heritage, our group operates six specialized operating companies spanning three core divisions: Medical Devices, Skincare & Cosmetics, and Functional Health Supplements. As Malaysia’s premier one-stop OEM/ODM medical device and health ecosystem, we provide uncompromised manufacturing standards for international exporters.
State-of-the-art ISO Class 8 (Class 100,000) cleanroom compounding and automated filling lines guaranteeing zero microbial contamination.
JAKIM Halal certified, GMP, HACCP, MDA Licensed, SEDEX/SMETA audited, and US FDA compliant manufacturing facility.
Over 60,000 tube units produced daily. Rapid R&D prototyping delivers customized sample batches in as fast as 24–48 hours.
Everything you need to know about custom OEM silicone scar gel production, compliance, MOQs, and private label exporting.
Partner with a trusted, CE Certified, ISO 13485 accredited OEM/ODM contract manufacturer. High daily capacity, turnkey dossier support, and clinical formulation excellence.
Get a Quote